Entering text into the input field will update the search result below

Cellectis Non-GAAP EPS of -$0.55 misses by $0.13, revenue of $3.56M misses by $2.54M

May 04, 2023 5:33 PM ETCellectis S.A. (CLLS)By: Pranav Ghumatkar, SA News Editor
  • Cellectis press release (NASDAQ:CLLS): Q1 Non-GAAP EPS of -$0.55 misses by $0.13.
  • Revenue of $3.56M (-7.0% Y/Y) misses by $2.54M.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About CLLS

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Cellectis S.A.
Innate Pharma S.A.
Harpoon Therapeutics, Inc.
Vanda Pharmaceuticals Inc.
Mesoblast Limited
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.